10 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18486913 | ADENOSINE DEAMINASE BASE EDITORS AND METHODS OF USING SAME TO MODIFY A NUCLEOBASE IN A TARGET SEQUENCE | BREEN, KIMBERLY CATHERINE | 1657 | Non-Final OA | Oct 13, 2023 |
| 18460178 | USES OF ADENOSINE BASE EDITORS | NOAKES, SUZANNE MARIE | 1656 | Final Rejection | Sep 01, 2023 |
| 18220874 | IONIZABLE LIPIDS FOR NANOMATERIALS | MOORE, SUSANNA | 1624 | Non-Final OA | Jul 12, 2023 |
| 18220867 | NANOMATERIALS COMPRISING AN IONIZABLE LIPID | SHTERENGARTS, SAMANTHA L | 1623 | Non-Final OA | Jul 12, 2023 |
| 18211840 | NANOMATERIALS COMPRISING CARBONATES | PATEL, SAGAR S | 1626 | Non-Final OA | Jun 20, 2023 |
| 18031547 | COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE DISEASE TYPE 1A | YU, DAVID TUYANG | 1635 | Non-Final OA | Apr 12, 2023 |
| 17430669 | ADENOSINE DEAMINASE BASE EDITORS AND METHODS OF USING SAME TO MODIFY A NUCLEOBASE IN A TARGET SEQUENCE | REGA, KYLE THOMAS | 1636 | Non-Final OA | Aug 12, 2021 |
| 17430274 | COMPOSITIONS AND METHODS FOR TREATING GLYCOGEN STORAGE DISEASE TYPE 1A | DACE DENITO, ALEXANDRA GERALDINE | 1636 | Final Rejection | Aug 11, 2021 |
| 17430289 | SPLICE ACCEPTOR SITE DISRUPTION OF A DISEASE-ASSOCIATED GENE USING ADENOSINE DEAMINASE BASE EDITORS, INCLUDING FOR THE TREATMENT OF GENETIC DISEASE | REGA, KYLE THOMAS | 1636 | Final Rejection | Aug 11, 2021 |
| 17054393 | METHODS OF SUPPRESSING PATHOGENIC MUTATIONS USING PROGRAMMABLE BASE EDITOR SYSTEMS | POPA, ILEANA | 1633 | Non-Final OA | Nov 10, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial